Budget Impact Analysis of Adding Dapaglifozin to the Therapy of Diabetes Mellitus Type 2 in Bulgaria

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.656
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Budget Optimization Analysis (BOA) of New Intervention Options for Type 2 Diabetes Mellitus

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pdb37 - Budget Impact Analysis of the Adult Type 1 Diabetes Mellitus National Clinical Guideline in Ireland

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Budget Impact Analysis of Biphasic Insulin Aspart in the Treatment of Type 2 Diabetes Mellitus in Malaysia: A Public Payer Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Budget Impact Analysis of Utilizing Canagliflozin (CANA) for the Treatment of Type 2 Diabetes Mellitus (T2DM) in an United States Health Plan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Pdb38 - Budget Impact Analysis of Benaglutide Injection in the Treatment of Type 2 Diabetes in China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Impact of Type 2 Diabetes Mellitus on Respiratory System

Journal of Modern Rehabilitation
2019English

Empagliflozin and Metformin Combination Therapy in Type 2 Diabetes Mellitus

International Journal of Basic and Clinical Pharmacology
2015English

Medication Adherence Analysis of Type 2 Diabetes Mellitus Patients

South East Asia Nursing Research
2019English

The Impact of Persistent Milk Consumption in the Pathogenesis of Type 2 Diabetes Mellitus

Functional Foods in Health and Disease
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy